Shuttle Pharmaceuticals (SHPH) News Today $1.67 -0.20 (-10.70%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination NewsNovember 2 at 5:36 AM | msn.comMicro Cap Company Is Soaring On Phase 2 Trial UpdateOctober 31 at 4:24 PM | theglobeandmail.com“Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs”October 30 at 8:44 AM | theglobeandmail.comShuttle Pharmaceuticals doses first patients in Phase 2 trial of RopidoxuridineOctober 30 at 8:44 AM | markets.businessinsider.comShuttle Pharmaceuticals (NASDAQ:SHPH) Stock, Short Interest ReportOctober 30 at 3:43 AM | benzinga.comShuttle Pharma Pays Off Senior Secured Convertible NoteOctober 30 at 3:43 AM | finance.yahoo.comShuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaOctober 30 at 3:43 AM | finance.yahoo.comShuttle Pharmaceuticals (NASDAQ:SHPH) Stock Quotes, Forecast and News SummaryOctober 30 at 3:43 AM | benzinga.comShuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesOctober 29, 2024 | globenewswire.comShuttle Pharmaceuticals Shares Rise 63% on Drug-Study Site UpdateOctober 29, 2024 | marketwatch.comShuttle Pharma Updates On Clinical Trial Site; Stock SurgesOctober 29, 2024 | markets.businessinsider.comShuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with GlioblastomaOctober 28, 2024 | globenewswire.comShuttle Pharmaceuticals Closes $790,000 OfferingThe pharmaceutical industry witnessed a significant financial development as Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) concluded an offering totaling $790,000. As detailed in a receOctober 28, 2024 | americanbankingnews.comShuttle Pharma advances glioblastoma treatment trialSeptember 19, 2024 | uk.investing.comShuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with GlioblastomaSeptember 16, 2024 | globenewswire.comShuttle Pharmaceuticals Files Delayed Financial Statements, Reports Progress on Drug StudySeptember 5, 2024 | marketwatch.comWhy Shuttle Pharmaceuticals (SHPH) Is Extremely Volatile TodaySeptember 5, 2024 | msn.comShuttle Pharma Provides Second Quarter 2024 Corporate UpdateSeptember 4, 2024 | globenewswire.comShuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price RequirementAugust 28, 2024 | markets.businessinsider.comShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)August 27, 2024 | finanznachrichten.deShuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)August 26, 2024 | globenewswire.comShuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaAugust 14, 2024 | globenewswire.comShuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONEJuly 19, 2024 | globenewswire.comShuttle Pharma Appoints Timothy Lorber as Chief Financial OfficerJune 18, 2024 | globenewswire.comShuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 22, 2024 | globenewswire.comShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides First Quarter 2024 Corporate UpdateMay 14, 2024 | finanznachrichten.deShuttle Pharma Provides First Quarter 2024 Corporate UpdateMay 14, 2024 | globenewswire.comSHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q1 2024May 13, 2024 | investorplace.comShuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 23, 2024 | globenewswire.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024April 3, 2024 | globenewswire.comShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Fourth Quarter 2023 Corporate UpdateMarch 22, 2024 | finanznachrichten.deShuttle Pharma Provides Fourth Quarter 2023 Corporate UpdateMarch 22, 2024 | finance.yahoo.comSHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q4 2023March 22, 2024 | msn.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024March 5, 2024 | globenewswire.comShuttle Pharma Announces Its Intent to Pursue a Rights OfferingFebruary 13, 2024 | finance.yahoo.comShuttle Pharmaceuticals Acquires Promising Prostate Cancer TechnologyFebruary 6, 2024 | msn.comShuttle Pharmaceuticals Bolsters Investor Relations with New PartnershipFebruary 6, 2024 | msn.comShuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024January 23, 2024 | finance.yahoo.comShuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaJanuary 8, 2024 | finance.yahoo.comShuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with GlioblastomaDecember 11, 2023 | finance.yahoo.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023November 30, 2023 | finance.yahoo.comShuttle Pharmaceuticals reports Q3 resultsNovember 14, 2023 | msn.comShuttle Pharmaceuticals Provides Third Quarter 2023 Corporate UpdateNovember 14, 2023 | finance.yahoo.comShuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License AgreementOctober 31, 2023 | finance.yahoo.comShuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor ConferenceOctober 10, 2023 | finance.yahoo.comShuttle Pharma Gets FDA Letter With Positive Feedback for RopidoxuridineSeptember 25, 2023 | marketwatch.comShuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with GlioblastomaSeptember 25, 2023 | finance.yahoo.comShuttle Pharma Participates in Hampton University Proton Therapy Institute Prostate Cancer & Men's Health FairSeptember 13, 2023 | finance.yahoo.comShuttle Pharma Expands Patent Coverage on HDAC Inhibitor PlatformSeptember 11, 2023 | finance.yahoo.comShuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer TherapeuticsAugust 29, 2023 | finance.yahoo.com Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here SHPH Media Mentions By Week SHPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHPH News Sentiment▼0.050.43▲Average Medical News Sentiment SHPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHPH Articles This Week▼130▲SHPH Articles Average Week Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TSBX News EDSA News AVTX News TRIB News VINC News ADXN News NKGN News GLYC News RDHL News PHXM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SHPH) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
